SEHK:2269Life Sciences
Assessing WuXi Biologics (SEHK:2269) Valuation After New GMP Certifications And PatroLab Launch
WuXi Biologics (Cayman) (SEHK:2269) recently reported two compliance and technology milestones: fresh UK MHRA GMP certifications for key Wuxi plants and the launch of its PatroLabTM digital twin bioprocess platform.
See our latest analysis for WuXi Biologics (Cayman).
The latest compliance wins and PatroLabTM launch come as the share price sits at HK$38.4, with a 30-day share price return of 15.87% and a 1-year total shareholder return of 117.69%, while longer term three and five year total...